Basal Cell Carcinoma Medications

1 · 5%

utilized to target actinic keratosis and intended to support the reduction of cancerous skin cell proliferation.

1 · 5%

This topical treatment is indicated to target precancerous skin lesions and certain carcinomas, formulated to alleviate damaged cell growth.